April 2022 - Page 2 of 28

FridayApr 29, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S. It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwide Over the 2022 calendar year, the company seeks to also pursue regulatory and commercial advancement In 2016, Lexaria Bioscience (NASDAQ: LEXX) received its first United States patent grant and over the years, the company has been aggressive at broadening its patent suite, a move which it has attributed to refining the patent claims…

FridayApr 29, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan The debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape products RWB expects to release its full-year 2021 results on May 2, with the management hosting a conference call on May 3 Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator on a mission to become the most recognizable cannabis company in the United States, is celebrating the fulfillment of its…

FridayApr 29, 2022 9:00 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Driving the Psychedelic Conversation Forward Through Education, Research, and Service Delivery

Delic is committed to bringing science-backed benefits to as many people as possible while also changing the narrative around psychedelics It seeks to achieve this through education, products and services, and research on psychedelics So far, LSD and psilocybin have proven to reduce end of life (“EOL”) anxiety for terminally ill patients Delic recognizes the potential of psychedelics and their application in therapeutics, hence its investment in research, civic education, and service delivery in this sector For many years, psychedelic drugs were frowned upon by society. This, along with psychedelics’ widespread popularity as recreational drugs in the 1960s and 70s,…

ThursdayApr 28, 2022 3:14 pm

QualityStocksNewsBreaks – Nowigence Inc. Streamlining How Teams Use Intelligence to Make Decisions, Complete Tasks

Nowigence provides a unique solution to the growing challenge of collaboration overload and the desperate need for tools that identify, organize and distribute information in a uniform way to provide access to critical information. The company accomplishes this through its Pluaris offering, which reads and analyzes articles, documents and other textual data, enabling users to learn more in less time, uncover hidden insights, and stay on top of the information they need to know. A recent article, which contains excerpts from Nowigence’s website, reads: “‘Communication is hard, and information is easily lost in translation, leading to duplication of effort in…

ThursdayApr 28, 2022 3:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research.…

ThursdayApr 28, 2022 2:40 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape

Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions in a commitment to transform the mental health treatment landscape. Through its proprietary deuterated process, Cybin is combining controllable drug-delivery systems with novel psychedelic molecules, thus creating patent-protected, commercially scalable drug candidates. “The company currently is moving three of these drug candidates forward: CYB003, CYB004 and CYB005. Cybin’s active drug programs target major depressive disorder (CYB003), alcohol use disorder (CYB003), anxiety disorders (CYB004) and neuroinflammation (CYB005),” reads a recent article. “Cybin recently announced that it commenced a…

ThursdayApr 28, 2022 1:43 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Evaluating Potential IP Acquisitions, Product Line Additions

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, and its subsidiary, Applied Magix Inc., is exploring potential acquisition opportunities that would expand the company’s essential intellectual property (“IP”) or product lines. Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar smart home and connected car markets, is investigating possible acquisition targets to add essential intellectual property to its line of products, as well as new product lines. According to Applied Magix CEO Dr. Harald Zink, Applied Magix is always on the lookout for new and innovative technologies and has recently identified several potential IP targets that are AI-based and…

ThursdayApr 28, 2022 1:34 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced its receipt of approval from the Spanish Agency for Medicines and Health Products (“AEMPS”) Competent Authority and from the CElm Provincial de Sevilla Ethics Committee in Spain for CNSP’s potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We continue to build momentum in our potentially pivotal study of Berubicin, and importantly advance toward bringing…

ThursdayApr 28, 2022 1:28 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Participate in Taglich Brothers Conference

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting during next month’s Taglich Brothers Investment Conference. The two-day event is scheduled for May 2–3, 2022, and will take place in New York City. GreenBox chair Ben Errez will be presenting during the event. His presentation will include a discussion of the company’s growing customized blockchain-based payment solutions along with an overview of the company’s strategic plans to become an integral presence in the digital payments landscape. Errez’s presentation is slated for May 2 at 4:15 p.m. ET. Taglich Brothers is a full-service brokerage firm specializing in…

ThursdayApr 28, 2022 1:06 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Deal to Provide Three ASRs to San Francisco Bay Area Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to make major progress in its focus on market expansion. The company just announced that a San Francisco Bay Area biotech real estate development will be provided with two of its K5 ASRs and one K1 ASR to enhance the client’s amenity-rich real estate project and underscore the importance of public safety in a highly regulated environment. “Biotech firms, like any other type of business, need to be protected from break-ins, vandalism, and other intrusions,” the company stated in the press release. “Unlike…

Site Search

Company Search

Month: April 2022

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Driving the Psychedelic Conversation Forward Through Education, Research, and Service Delivery

QualityStocksNewsBreaks – Nowigence Inc. Streamlining How Teams Use Intelligence to Make Decisions, Complete Tasks

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Evaluating Potential IP Acquisitions, Product Line Additions

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Participate in Taglich Brothers Conference

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Deal to Provide Three ASRs to San Francisco Bay Area Client

Market Basics

Newsletter Publishers

Public Companies